TEMARIL-P- trimeprazine tartrate and prednisolone tablet

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

TRIMEPRAZINE TARTRATE (UNII: 362NW1LD6Z) (TRIMEPRAZINE - UNII:76H78MJJ52), PREDNISOLONE (UNII: 9PHQ9Y1OLM) (PREDNISOLONE - UNII:9PHQ9Y1OLM)

Available from:

Zoetis Inc.

INN (International Name):

TRIMEPRAZINE TARTRATE

Composition:

TRIMEPRAZINE 5 mg

Administration route:

ORAL

Prescription type:

PRESCRIPTION

Therapeutic indications:

Temaril-P is recommended for the relief of itching regardless of cause. Its usefulness has been demonstrated for the relief of itching and the reduction of inflammation commonly associated with most skin disorders of dogs such as the eczema caused by internal disorders, otitis, and dermatitis (allergic, parasitic, pustular, and nonspecific). It often relieves pruritus which does not respond to other therapy. With any pruritus treatment, the cause should be determined and corrected; otherwise, signs are likely to recur following discontinuance of therapy. Temaril-P has been found to be effective therapy and adjunctive therapy in various cough conditions of dogs. Therefore, in addition to its antipruritic action, Temaril-P is recommended for the treatment of "kennel cough" or tracheobronchitis, bronchitis including all allergic bronchitis, and infections and coughs of nonspecific origin. (Coughs due to cardiac insufficiencies would not be expected to respond to Temaril-P therapy.) As with any antitussive treatm

Product summary:

100- and 1000-tablet bottles.

Authorization status:

New Animal Drug Application

Summary of Product characteristics

TEMARIL-P- TRIMEPRAZINE TARTRATE AND PREDNISOLONE TABLET
ZOETIS INC.
----------
TEMARIL-P
_TEMARIL-P _
_(TRIMEPRAZINE WITH PREDNISOLONE) _
_TABLETS_
_ANTIPRURITIC–ANTITUSSIVE–ANTI-INFLAMMATORY_
_For use in dogs_
CAUTION
Federal law restricts this drug to use by or on the order of a
licensed veterinarian.
DESCRIPTION
Each tablet contains trimeprazine tartrate (USP)
10-[3-(Dimethylamino)-2-methylpropyl]
phenothiazine tartrate (2:1) equivalent to trimeprazine, 5 mg, and
prednisolone, 2 mg.
ACTION
The exclusive Temaril-P formula combines the antipruritic and
antitussive action of
trimeprazine with the anti-inflammatory action of prednisolone. A
therapeutic effect is
attained by administering the tablets twice daily.
INDICATIONS AND USAGE
1. ANTIPRURITIC
Temaril-P is recommended for the relief of itching regardless of
cause. Its usefulness
has been demonstrated for the relief of itching and the reduction of
inflammation
commonly associated with most skin disorders of dogs such as the
eczema caused by
internal disorders, otitis, and dermatitis (allergic, parasitic,
pustular, and nonspecific). It
often relieves pruritus which does not respond to other therapy. With
any pruritus
treatment, the cause should be determined and corrected; otherwise,
signs are likely to
recur following discontinuance of therapy.
2. ANTITUSSIVE
Temaril-P has been found to be effective therapy and adjunctive
therapy in various
cough conditions of dogs. Therefore, in addition to its antipruritic
action, Temaril-P is
recommended for the treatment of "kennel cough" or tracheobronchitis,
bronchitis
including all allergic bronchitis, and infections and coughs of
nonspecific origin. (Coughs
due to cardiac insufficiencies would not be expected to respond to
Temaril-P therapy.)
®
_®_
As with any antitussive treatment, the etiology of the cough should be
determined and
eliminated if possible. Otherwise, symptoms are likely to recur
following discontinuance
of therapy.
NOTE: Temaril-P may be administered to animals suffering from acute or
chronic
b